-

Jay Bhaumik’s Visionary Leadership Propels Thesis Pharmacy to 2025 Inc. 5000 List

Thesis Pharmacy has been named among the fastest-growing private companies in the U.S. by Inc. Magazine.

PLANO, Texas--(BUSINESS WIRE)--Thesis Pharmacy has earned the rank of No. 988 on the 2025 Inc. 5000 list, recognizing the company as one of the fastest-growing private businesses in the United States. Achieving a remarkable 433% three-year growth, Thesis Pharmacy continues to advance its mission of providing personalized pharmacy services through innovation, specialized compounding, and complementary home delivery.

“We are honored to be included among the elite businesses recognized by Inc. Magazine,” said Dr. Jay Bhaumik. “This honor reflects our team’s relentless dedication to patient‑centered care, creative compounding solutions, and delivering medications directly to patients at minimal to no cost. We remain committed to developing extended services and expanding access in our communities.”

Located in Plano, Texas, Thesis Pharmacy has grown rapidly, offering specialized offerings in wellness, anti‑aging, ophthalmology, and men’s and women’s health among therapeutic areas. The pharmacy’s compounding expertise enables custom medication formulations tailored to unique patient needs, from dermatology and sports medicine to veterinary care.

Dr. Bhaumik, a serial entrepreneur and healthcare innovator, brings over 20 years of experience in pharmaceutical leadership and health IT. He has previously led startups in healthcare cybersecurity and health information systems to successful exits, and his strategic vision guides product development, compliance, and transformative growth initiatives at Thesis Pharmacy.

As Thesis Pharmacy embarks on its latest phase of expansion, the company continues to invest in technology‑enabled fulfillment, prescriber concierge services, and patient education efforts to further its outreach and positive outcomes.

Thesis Pharmacy, based in Plano, TX, specializes in customized compounding solutions and personalized patient care. With a focus on wellness, anti-aging, dermatology, men’s and women’s hormone therapy, ophthalmology, and sports medicine, the pharmacy delivers innovative, tailored healthcare solutions while maintaining competitive costs.

Dr. Jay Bhaumik is a visionary leader in the healthcare industry with a distinguished career spanning clinical positions at Yale University and Johns Hopkins. He has led Thesis Pharmacy to national recognition, leveraging his entrepreneurial spirit to drive success in healthcare and technology.

For more news and information about Thesis Pharmacy, visit http://thesispharmacy.com

Contacts

Media Contact: Autumn Arnold
Phone: 469-871-0172
Email: pr@texasstarpharmacy.com

Thesis Pharmacy


Release Versions

Contacts

Media Contact: Autumn Arnold
Phone: 469-871-0172
Email: pr@texasstarpharmacy.com

More News From Thesis Pharmacy

Jay & Raman Bhaumik Announce Thesis Pharmacy Rebranding from Texas Star, Signaling Precision Growth and National Expansion

PLANO, Texas--(BUSINESS WIRE)--Thesis Pharmacy today announced its official rebrand from Texas Star Pharmacy, marking a major milestone in its growth as a leading national compounding provider licensed in over 40 states. Co-owners Raman and Jay Bhaumik selected the name Thesis Pharmacy to reflect its foundation in research, precision, and purpose-driven care. The rebrand underscores the company’s commitment to clinical excellence, quality compounding, and innovative, personalized solutions. The...

Raman Bhaumik to Represent Thesis Pharmacy at A4M Longevity Fest 2025

PLANO, Texas--(BUSINESS WIRE)--Raman Bhaumik, an entrepreneur and licensed pharmacist, will represent Thesis Pharmacy at A4M’s Longevity Fest 2025, held December 12–14, 2025, at The Venetian and Palazzo Resort in Las Vegas. The event, hosted by the American Academy of Anti-Aging Medicine (A4M), is widely recognized as one of the most influential gatherings for longevity and wellness professionals worldwide. Thesis Pharmacy will host a booth at the conference, providing an opportunity to share i...
Back to Newsroom